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Objectives: An employee with no prior history of allergy or asthma, experienced respiratory and ﬂu-like
symptoms during production of shrimp shell powder in a seafood savory factory in Norway. We aimed to
clarify the diagnosis and to identify the cause of the symptoms by speciﬁc inhalation challenge (SIC) and
by characterizing the powder's biocontaminants, particle size fractions and inﬂammatory potential.
Methods: Respiratory and immunological responses were measured the day before and after each of four
challenges with 20–150 g shrimp shell powder during three consecutive days. The powder was analyzed
for endotoxin, microorganisms and particle size fractions by standardized laboratory methods. Total
inﬂammatory potential was quantiﬁed by reactive oxygen species (ROS) production in a granulocyte
assay.
Results: The patient had elevated IgG, but not IgE, towards shrimp shell powder. 20 min challenge with
150 g shrimp shell powder induced 15% decrease in FVC, 23% decrease in FEV1 and increased unspeciﬁc
bronchial reactivity by methacholine. Neutrophils and monocytes increased 84% and 59%, respectively,
and the patient experienced temperature increase and ﬂu-like symptoms. The shrimp shell powder
contained 1118 endotoxin units/g and bacteria including Bacillus cereus, and 57% respirable size fraction
when aerosolized. The ROS production was higher for shrimp shell powder than for endotoxin alone.
Conclusions: Endotoxin and other bacterial components combined with a high fraction of respirable dust
might be the cause of the symptoms. The patient's characteristics and response to SIC were best com-
patible with occupational asthma and organic dust toxic syndrome, while hypersensitivity pneumonitis
could not be excluded.
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Occupational exposure to bioaerosols may be associated with
increased inﬂammation of the airways. Occupational exposures
are often characterized with peak or continuous exposure to much
higher levels of contaminants and dust than usually encountered
outside the working environment. Thus, occupational bioaerosol
exposure may cause severe health effects that may be eitherInc. This is an open access article u
ational Medicine, Haukeland
orway.temporary or permanent, depending on host factors and the type
and duration of exposure. In addition to nonspeciﬁc symptoms of
mucous membrane irritation, workers may be at risk of pulmonary
illnesses such as occupational asthma and bronchitis, organic dust
toxic syndrome (ODTS), and hypersensitivity pneumonitis (HP)
(Granslo et al., 2009; Madsen et al., 2012; Morell et al., 2011; Raulf
et al., 2014; Sigsgaard and Schlunssen, 2004; Smit et al., 2006;
Spaan et al., 2006; Villar et al., 2014). The different disease pre-
sentations may depend on the site of the dusts’ deposition in the
respiratory system; bronchitis and asthma are associated with
particle deposition in the bronchi and upper airways, while ODTS
and HP are typically associated with particles depositing in the
alveoli (Raulf et al., 2014).nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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dustries involving biological agents are typically exposed to
bioaerosols with proteins (allergens) from various sources, as well
as a range of contaminants including endotoxins, insect fragments,
and microorganisms (Abdel Rahman et al., 2012; Basinas et al.,
2012; Baur and Bakehe, 2014; Gautrin et al., 2010; Helaskoski et al.,
2014; Kogevinas et al., 2007; Malo et al., 1997; Mapp et al., 2005;
Thorne et al., 2004). The bioaerosols may lead to diseases such as
asthma (e.g. baker's asthma) and HP (e.g. farmer's lung) (Basinas
et al., 2012; Baur and Bakehe, 2014; Gautrin et al., 2010; Madsen
et al., 2012; Malmberg et al., 1988; Morell et al., 2011; Rylander
et al., 1989; Seifert et al., 2003; Thorne et al., 2005; Villar et al.,
2014). Chitin is a major component of crustacean shell. Since lack
of the chitin degrading enzyme chitinase is associated with an
increased risk for asthma (Brinchmann et al., 2011), chitin has
been discussed as a causative agent for asthma speciﬁcally for
workers involved in crustacean processing. Human experiments
indicate that chitin might have an immunomodulatory effect,
driving the immune system away from a type 2 response, hence,
diminishing the tendency to sensitization in the workforce (Sigs-
gaard et al., 2015). However, with regard to respiratory illness in
the working environment, tropomyosin and not chitin appear to
be the most likely offending agent (Bonlokke et al., 2012; Cartier
et al., 2004; Malo et al., 1997). High levels of aerosolized allergens
such as tropomyosin have been described as important risk factor
for the development of occupational asthma, as reported from
snow crab processing plants (Abdel Rahman et al., 2012; Bonlokke
et al., 2012; Cartier et al., 2004; Gautrin et al., 2010). Endotoxin is a
constituent of the cell wall of Gram-negative bacteria and are
ubiquitous in the environment, but very high exposure (e.g.
410,000 Endotoxin units (EU)/m3) has mainly been reported for
speciﬁc occupational groups, in particular within agriculture and
life-stock farming (Basinas et al., 2012, 2013, 2015; Smit et al.,
2006; Spaan et al., 2006), and for very speciﬁc production works,
such as grass seed and bacterial proteins for animal and ﬁsh feed
(Madsen et al., 2012; Sikkeland et al., 2008) and in cotton and
other textile plant manufacturing (Er et al., 2016; Hinson et al.,
2014). Exposure to endotoxin is associated with airway symptoms
including nasal symptoms, bronchoconstriction and lung function
decline, and high exposure levels may cause HP and ODTS (Mad-
sen et al., 2012; Michel, 2000, 1997; Rylander et al., 1989; Sigs-
gaard et al., 2005; Thorne, 2000; Timm et al., 2009). Long term
occupational exposure to high levels of endotoxin may cause
permanent lung damage (Skogstad et al., 2012) and speciﬁc ill-
nesses such as byssinosis (Er et al., 2016).
In the present study, we investigated one patient referred to
our clinic experiencing fever, chills, and respiratory symptoms
while working with shrimp shell powder production in a seafood
savory factory. The aim of the study was to clarify the diagnosis
and to identify the cause of the symptoms by speciﬁc inhalation
challenge (SIC) and by characterizing the powder's biocontami-
nants, particle size fractions and inﬂammatory potential.2. Material and methods
2.1. Production facility
The production plant is part of a special marine ingredients
company producing 100% natural ingredients to the savory and
nutritional markets. The plant produces different marine savory
seafood ingredients, like seafood and shellﬁsh powders and
granules from codﬁsh, arctic ﬁsh, shrimp, and shrimp shell.
Shrimp powder is produced by cooking, drying and grinding
whole shrimps in the production facility in Norway, whereas
shrimp shell powder is produced from pre-made granules (coarsepowder). The granules originate from dried and grinded shell re-
moved from cooked shrimps. The production plant receives
shrimp shell granules from two Canadian and one Norwegian
company, which all use the same shrimp species, Pandalus borealis.
The shrimp shell granules are shipped in “big-bags” to the pro-
duction facility where they are grinded into powder and packed in
smaller bags. The product speciﬁcation for seafood savory powder
in general states that 95% of the product should be below 200 mm,
whereas for the shrimp shell powder 85% is below 100 mm, the
latter being mainly inhalable. The raw material and end product is
tested for microorganisms (total bacteria count, En-
terobacteriaceae, E. coli, Salmonella, mould/yeast) and approved for
distribution only if the concentrations are below pre-deﬁned
limits set to avoid food-related health hazards. The quality control
does not include tests for microbial byproducts, such as endotoxin.3. Speciﬁc inhalation challenge
3.1. Subject
The patient, a 48 year old never-smoking woman, with no prior
medical history of allergy or asthma, was referred to Department
of Occupational Medicine at Haukeland University Hospital in
Bergen, Norway, due to respiratory (dyspnea, cough with phlegm,
occasional wheezing) and ﬂu-like symptoms (fever, joint aches,
chills, fatigue) during the workdays and in the evenings and nights
following work with shrimp shell powder. The patient did not
experience symptoms when involved in the production of other
marine savory seafood ingredients including cod powder and
powder from whole shrimp. The patient reported to have had
respiratory and ﬂu-like symptoms from the very ﬁrst week the
company started producing shrimp shell powder (approximately
one year prior to referral). All the symptoms got progressively
worse during a work week, with some lessening during weekends,
but could last as long as three weeks after exposure. Examination
prior to SIC, at which time the patient had been out of exposure for
several weeks, showed a healthy individual with no observed or
reported respiratory symptoms. Forced Volume Capacity (FVC),
Forced Volume in 1 second (FEV1), carbon monoxide diffusing
capacity of the lung (DLCO) and fraction of exhaled NO (FeNO)
were within reference values and there was no sign of bronchial
hyperresponsiveness with a methacholine provocation test
(PC20416). The patient had a total IgE level of 17 kU/L, negative
Phadiatops and food allergy panel, and no elevated serum IgE
towards shrimp. She could consume shrimps without having any
symptoms.
3.2. Speciﬁc inhalation challenge
Speciﬁc inhalation challenge was performed in an inhalation
chamber (12.8 m3). On the ﬁrst day with challenge, the patient
was exposed to lactose powder (Lactose monohydrat GPR REC-
TAPUR (product number: 24945.360), VWR Chemicals, Leuven,
Belgium) by dust tipping from one tray to another 30 cm distance
from the face for 10 min as a control (placebo) (E0). In the absence
of any signiﬁcant change in FEV1 within the next hour, the patient
was exposed to 20 g shrimp shell powder granules mixed with
150 g lactose powder for 10 min (E1). The challenges continued
with increasing exposure (increased concentration of shrimp shell
powder and increased duration of challenge) over the next two
days (Appendix Table A.1).
Shrimp shell powder produced in the factory was used during
SIC. For dosage we took into account the endotoxin concentration
in the shrimp shell powder and assumed a similar aerosol con-
centration in the air as previously measured by a direct reading
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Shoreview, MN, US) in the inhalation chamber for similar agents
(powders) mixed with lactose. The maximum concentration of
endotoxin exposure was estimated to be 64 EU/m3 (Appendix
Table A.1). Compared to high endotoxin levels reported from var-
ious occupational settings (e.g. 5800–11,000 EU/m3 (Skogstad
et al., 2012) and 636–16,300 EU/m3 (Seifert et al., 2003)) we con-
sidered the calculated maximum dosage not to be harmful upon
SIC challenge.
3.3. Evaluation of clinical response from SIC
Lung function (FEV1 and FVC), auscultation results, nasal visual
analog scale (VAS) scores, and body temperature was recorded
before and immediately after each challenge, then every 10 min
for the ﬁrst 60 min and thereafter every hour the rest of the
working day. After the patient left the hospital she measured FEV1
with a hand-held spirometer (Jaeger AM1þ , Visays Healthcare
GmbH, Hoechberg, Germany) every hour until going to sleep,
during the night if she woke up due to respiratory distress, im-
mediately after waking up in the morning and every hour until
arriving at the hospital the next day. For asthma, a positive SIC was
deﬁned by a fall in FEV1Z15% from baseline, according to the
consensus statement by the European Respiratory Society's task
force (Vandenplas et al., 2014).
3.4. Evaluation of immunological response
Blood samples were collected in the afternoon on the day be-
fore the ﬁrst challenge, post exposure every day with challenges
and approximately 24 h after the last challenge. Leukocyte counts
and CRP were assessed daily, and a large panel of immunological
markers were assessed the day before and after challenge: ECP
(eosinophil cationic protein), tryptase, lymphocyte im-
munophenotyping: CD3 T-cells, CD3/CD4 T-helper cell ratio, CD19
B-cells, CD56 NK-cells, CD4/CD8-ratio; Immunoglobulines: total
IgE, IgA, IgM, IgG, IgG subclasses IgG1, IgG2, IgG3, IgG4, and
quantiﬁcation of complement factor C3 and C4.
3.5. IgE and IgG shrimp shell protein-binding
A DC protein assay (BIO-RAD, Richmond, CA, USA) was used to
quantify protein concentrations in shrimp shell granules, shrimp
shell powder and codﬁsh powder (produced at the same factory
and used as control). Protein was extracted from the shrimp shell
powder and tested for IgE- and IgG-binding with serum from the
patient who underwent the SIC procedure. The proteins which
were isolated from shrimp shell powder include tropomyosin (the
main shellﬁsh allergen) as well as other proteins (allergens) from
shrimp shell. Binding of anti-shrimp IgE (with IgE isolated from
sera from patients with veriﬁed shrimp allergy) to proteins iso-
lated from the shrimp shell powder veriﬁed the presences of
shrimp allergens in the powder.4. Assessment of biocontamination, particle size distributions
and inﬂammatory potential in the shrimp shell powder
4.1. Endotoxin analyses
The concentration of endotoxin was measured in the shrimp
shell powder and in the shrimp shell granules (from two different
batches) and in codﬁsh powder (used as control substance) by the
Kinetic-QCL™ Kinetic Chromogenic LAL Assay at the School of
Public Health, Aarhus University, Denmark. The analyses was
performed prior to the SIC, with the intention to verify ifendotoxin was present and if so, take into account the con-
centration when planning the amount of shrimp shell powder to
be used during challenges.
4.2. Aerosolisation, particle sampling and extraction of particles
The shrimp shell granules and powder from shrimp shell and
codﬁsh were aerosolized in order to determine particle size frac-
tions and to generate aerosol samples to be used in cell assays and
for cultivation of fungi and bacteria. Details of the aerosolisation
and particle sampling (481, 1993) are described in the Appendix.
The dust collected by polycarbonate ﬁlters during aerosolisa-
tion was extracted by placing ﬁlters in 5 ml sterile water solution
with 0.0005% Tween 80 for the cell assays and 0.05% Tween 80 for
both the endotoxin assay and cultivation of bacteria and fungi. The
ﬁlters were shaken orbitally for 60 min (500 rpm) at room tem-
perature. The suspension for endotoxin measurement was cen-
trifuged (1000g) for 15 min and the supernatant was used for
endotoxin analysis.
4.3. Measurement of the total inﬂammatory potential
The inﬂammatory effects induced by the various aerosol frac-
tions were quantiﬁed by TIP in a granulocyte assay (Timm et al.,
2009) at the National Research Centre for the Working Environ-
ment, Copenhagen, Denmark. The assay is based on the differ-
entiated HL-60 cell-line which, upon exposure to microbial com-
pounds, will react by producing reactive oxygen species (ROS),
quantiﬁable by a luminol dependent chemiluminometric assay
(Timm et al., 2006) (see Appendix for details).
4.4. Quantiﬁcation of endotoxin, NAGase, and identiﬁcation of bac-
teria and fungi in the various particle size fractions
The supernatants from the 18 aerosol samples were analyzed
for endotoxin content in duplicate at the National Research Centre
for the Working Environment, Copenhagen, Denmark. The kinetic
Limulus Amoebocyte Lysate test (Kinetic-QCL endotoxin kit, Bio-
Whittaker, Walkersville, Maryland, USA) was used. A standard
curve obtained from an Escherichia coli O55:B5 reference en-
dotoxin was used to determine the concentrations in terms of
endotoxin units (EU) (10.0 EU¼1.0 ng). The methods used to
quantify the activities of the chitinase NAGase and identiﬁcation of
bacteria and fungi in the various particle size fractions are de-
scribed in the Appendix.
This study was approved by the Regional Committee for Med-
ical and Health Research Ethics (2015/61). The company and the
patient consented to publication of the results.5. Results
5.1. Clinical
At the start of each challenge (except for placebo challenge),
the patient experienced a short period of breathlessness and after
challenges E3 and E4, she also experienced dyspnea. Several hours
after challenges the patient experienced cough with phlegm,
chills, headache and joint pains; these symptoms were qualita-
tively similar to, but milder than the symptoms she experienced
during work with shrimp shell powder in the factory. She did not
experience wheezing from the chest, and there were no wheezing
sounds at auscultation at any time during the week with chal-
lenges. On the second day with challenge, the patient had an in-
crease in temperature from 36.3 °C (the patient's normal body
temperature) before the challenge to 37.5 °C in the evening after
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tient had no respiratory or other symptoms, as well as normal
spirometry, diffusion capacity and FeNO. She repeated spirometry
which was normal as was diffusion capacity and FeNO. A border-
line positive methacholine provocation test (PC20 13.7 mg/ml) in-
dicated increased bronchial hyperresponsiveness (Crapo et al.,
2000).
5.2. Lung function
The day of the ﬁrst low-dose challenges, a late reaction was
indicated with almost 10% lower FEV1 values after 10–12 h, coin-
ciding with mild symptoms (Fig. 1). Signiﬁcant acute effects of the
shrimp shell powder challenges were observed for FVC with a 15%
fall after E4 (150 g shrimp shell powder for 20 min) and for FEV1
with a 19% fall from baseline after E3 (150 g shrimp shell powder
for 10 min) and 23% fall in FEV1 after E4 (Fig. 1). On both occasions,
FVC and FEV1 fell within a few minutes after the challenge, started
to increase again 10 min after the challenges, and then increased
gradually during the ﬁrst hour after challenge but never reached
the baseline level from Day 0; the percentage changes of FEV1 after
challenges is shown in Fig. 1.
5.3. Immunology
The neutrophil count increased from 1.9109/L at baseline to
3.5109/L (84% increase) after the second day with challenge. The
monocyte count increased from 0.27109/L to 0.43109/L (59%
increase), and the lymphocytes count decreased from 2.0109/L
to 1.5109/L (25% decrease) after the second day with challenge.
The blood cell counts were still higher on the third and last day
(after challenge) as compared to baseline, but not as high as the
levels measured on the second day with challenge. CRP increased
from 1 mg/L to 5 mg/L, whereas the other immunological markers
did not change noticeably from before to after challenge (Appen-
dix Table A.2).
5.4. Protein concentration and speciﬁc IgE and IgG
The concentration of proteins in the shrimp shell granules and
powder was similar (16.2% and 17.4%, respectively) and slightly
lower than the protein concentration in the codﬁsh powder
(22.0%). Both the granules and the shrimp shell powder contained
shrimp-antigen as veriﬁed by anti-shrimp IgE from patient seraFig. 1. Change in FEV1 (% from baseline measured at Day 0) after speciﬁc inhalation
challenges with placebo and with shrimp shell powder by increasing concentra-
tions and/or increasing challenge duration. “Start Jaeger self-registration” denotes
the time when the patient leaves the hospital and continues FEV1 measures by
handhelp device. The ﬁrst FEV1 point for the control day starts at 4 h as this ﬁrst
point is measured during the same time of day.with veriﬁed shrimp-allergy. However, there was no IgE-binding
in serum from the SIC-patient, and the conventional shrimp al-
lergen IgE test was also negative, conﬁrming that the patient was
not sensitized to tropomyosin or any other shrimp allergens. On
the contrary, the patient had 28 times higher titer of IgG towards
shrimp shell powder proteins (1.291, Abs 405 nm) as compared to
the IgG titer from pooled sera from patients with veriﬁed shrimp
allergy (0.046, Abs 405 nm).
5.5. Particle size distribution
The laboratory-generated aerosols of the shrimp shell powder
were measured to have 88.7%, 83.6% and 51.9% particles of inhal-
able, thoracic and respirable size, respectively. The aerosols from
shrimp shell granules consisted of 89.6% inhalable, 86.0% thoracic
and 57.0% respirable size particles and for codﬁsh powder 88.8%,
83.3% and 55.3% inhalable, thoracic and respirable size, respec-
tively. The concentration (arbitrary units) as function of aero-
dynamic diameter (Appendix Fig. A.1) shows that more particles
were aerosolised from the two shrimp shell products than from
the codﬁsh powder.
5.6. Endotoxin
The endotoxin concentration was higher in the shrimp shell
powder (4099 EU/g) than in the shrimp shell granules (1118 EU/g)
and the codﬁsh powder (877 EU/g). The concentrations of en-
dotoxin in inhalable dust fractions differed signiﬁcantly between
the three products (shrimp shell granules and powder and codﬁsh
powder) (Fig. 2(a)). The concentration of inhalable endotoxin that
was aerosolized per minute from 2 g of each product was also
signiﬁcantly different from each other, with the highest release
measured from shrimp shell powder (Fig. 2(b)).
5.7. Total inﬂammatory potential (TIP)
The TIP measured as a cell response to exposure to inhalable,
PM4, and PM1 dust fractions were signiﬁcantly different for the
three products (all po0.001 between groups (ANOVA) (Table 1)).
The ROS production proﬁle of endotoxin and shrimp shell powder
is given in Fig. 3. The inhalable dust fractions showed a dose-re-
sponse for the two shrimp shell dust samples (data not shown). A
large part of the TIP response was caused by the water soluble
fraction of the dust. For both the shrimp shell powder and shrimp
shell granules, the cell response was higher when stimulated with
inhalable compared to PM4 or PM1 dust fractions (Table 1). Dilu-
tion of the PM4 fractions of all three products and PM1 fractions of
shrimp shell granules and codﬁsh powder caused increased cell
reaction, indicating a cytotoxic response. Thus, the TIP of PM4 and
PM1 samples increased until the samples were 20 and 10 times
diluted, respectively. Spiking with endotoxin caused an increased
inﬂammatory response of both diluted and undiluted samples
(data not shown). For the undiluted PM4 and PM1 samples the
highest TIP was found for shrimp shell powder and the lowest for
codﬁsh powder (Table 1).
5.8. Bacteria, NAGase and fungi
A signiﬁcantly higher concentration (po0.01) of total bacteria
was found in the inhalable dust from shrimp shell granules
(135 CFU/mg) compared with inhalable dust from codﬁsh powder
(2 CFU/mg) (Table 2). The highest activity of NAGase was found in
the PM4 fractions (Table 2). No signiﬁcant difference was found in
the concentration of total bacteria in the PM4 fractions of the three
products. Bacillus cereus constituted the majority of bacteria iso-
lates present in the dust samples and was, with the exception of
Fig. 2. Average amounts of endotoxin (EU) (a) per mg dust and (b) average amount of endotoxin per minute aerosolized from 2.0 g shrimp shell powder or granules or
codﬁsh powder as measured in inhalable, PM4 or PM1 dust. Bars followed by the same letter are not statistically signiﬁcant different.
Table 1
Total Inﬂammatory Potential (average, median, range and n) of dust suspensions and of the water soluble fraction of inhalable, PM4 and PM1 dust from shrimp shell and
codﬁsh powder.
Inhalable, undiluted RLU** PM4, undiluted RLU PM4, diluted 20 RLU PM1, undiluted RLU PM1, diluted 10 RLU
Shrimp shell
powder
Suspension 2.02105 a* 4.00104 a 1.22104 a
1.47105 4.43 104 [2.65104–3.63104] 1.19104 [3.41104–3.77104]
[6.83104–4.40105] [2.26104–5.50104] 2 [1.08104–1.41104]
8 6 4 2
Soluble 5.76104 b – – – –
5.79 104
[5.001046.47104]
3
Shrimp shell
granules
Suspension 3.39105 a 1.58104 b 9747 b
1.73 105 1.56 104 [3.80104–5.00104] 7524 [3.88104–4.53104]
[1.11105–8.93105] [1.20104–1.94104] 2 [5360–1.03104] 2
8 6 4
Soluble 1.38105 a – – – –
1.37 105
[9.01104–1.85105]
3
Codﬁsh powder Suspension 5604 c 7649 c 4379 c
5145 8375 [2.39104–2.53104] 4452 [2.05104–3.05104]
[4.95103–7.05103] [5098–9840] 2 [4880–5405] 2
6 6 4
Soluble 3722 c – – – –
3702
[3590–3963]
3
* Numbers in the same column followed by the same letter are not signiﬁcantly different.
** RLU represents accumulated RLU over the 180-min. cell response time. n¼ total number of samples.
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from the three products. The concentration of B. cereus in inhalable
dust was found to be signiﬁcantly higher (po0.05) in shrimp shell
granules than in codﬁsh powder (Table 2). In addition to B. cereus,
Micrococcus luteus was identiﬁed in both the inhalable and PM4
dust fraction of the shrimp shell powder, while Jeotgalicoccus ha-
lotolerans and Arthrobacter creatinolyticus were identiﬁed in in-
halable dust from shrimp shell granules.
Fungi were detected in the PM4 fraction of all the 3 products
and in the inhalable dust from shrimp shell granules and codﬁsh
powder, but not in the inhalable dust from the shrimp shellpowder. The concentration of total fungi in the PM4 fraction was
signiﬁcantly higher (po0.05) in shrimp shell granules (36 CFU/
mg) compared with codﬁsh powder (4 CFU/mg) (Table 2). Peni-
cillium chrysogenumwas found both in shrimp shell powder (PM4),
shrimp shell granules (PM4) and codﬁsh powder (inhalable and
PM4), but no signiﬁcant difference in concentrations were ob-
served (Table 2). Aspergillus fumigatus and Penicillium rugulosum
were identiﬁed in the PM4 fraction of both shrimp shell powder
and shrimp shell granules. Moreover, A. fumigatus was found in
inhalable dust from the shrimp shell granules. Neither A. fumigatus
nor P. rugulosum was found in dust from the codﬁsh powder.
Fig. 3. Example on response proﬁles in the granulocyte. The granulocyte-like cells
were stimulated at time zero with inhalable dust from shrimp shell powder, en-
dotoxin, and a reference (HBSS). Light intensity (in RLU/s) was measured for 1 s
every two minutes for 180 min.
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Exposure to shrimp shell powder during SIC caused 15% de-
crease in FVC, 23% decrease in FEV1, 1.2 °C rise in body tempera-
ture, 84% rise in neutrophils and symptoms of dyspnea, coughTable 2
Concentrations of microbial species (CFU/mg dust; [Range]) and activity of the enzyme
shell powder, shrimp shell granules and codﬁsh powder.
Microorganism Geometric mean concentration of aerosolized micr
Shrimp shell powder Shrim
Inhalable PM4 Inhal
All bacteria 1.42101 3.96100 1.35
[2.46100–1.18102] [BD–1.05101] [4.07
aba b a
Arthrobacter creatinolyticus BDb BD 2.19
[5.09
Bacillus cereus 1.19х101 BD 5.57
[BD–1.18102] [5.09
ab a
Jeotgalicoccus halotolerans BD BD 4.79х
[BD–2
Micrococcus luterus 1.46100 3.96100 BD
[BD–2.46100] [BD–1.05101]
a a
Unidentiﬁed bacteria BD BD 3.20
[BD–5
All Fungi BD 2.15101 3.03
[BD–1.37102] [BD–
ab bc
Aspergillus fumigatus BD 6.73100 3.03х
[BD–1.90101] [BD–2
ab bc
Penicillium chrysogenum BD 1.33101 BD
[BD–1.37102]
a
Penicillium rugulosum BD 3.96100 BD
[BD–3.16100]
b
NAGase* 0.062 0.23 0.056
[0.055–0.067] [0.22–0.24] [0.04
b a bc
* A chitinase EC3.2.1.30.
a Concentrations in the same row with same letter are not signiﬁcantly different
concentration corresponding to half of the detection limit was used for statistical calcu
b BD: Concentration below the detection limit of the method.with phlegm, chills, headache and joint pains in a women working
in a seafood savory factory. The patient had elevated levels of IgG,
but not IgE, towards shrimp shell proteins. The shrimp shell
powder had high concentrations of endotoxin, and the respirable
dust represented more than 50% of the measured inhalable frac-
tion. The patient experienced no symptoms when working with
codﬁsh powder; this powder had much lower inﬂammatory po-
tential than the shrimp shell powder.
Speciﬁc inhalation challenge allows for the delivery of deﬁned
levels of the suspected agent in a controlled environment to en-
sure adequate characterization of exposure for a speciﬁc duration.
The protocol for the present SIC reported in this paper is based on
a consensus statement which provides practical recommendations
for the use of SIC in the diagnosis of occupational asthma (Van-
denplas et al., 2014). With regard to allergic asthma, we did not
consider this as a likely diagnosis, as the patient did not have
elevated speciﬁc IgEs towards tropomyosin or other potential
sensitizing allergens isolated from the shrimp shell powder and
total IgE of 17 kU/L. Furthermore, the patient had symptoms on the
very ﬁrst week she started working with shrimp shell powder, and
thus, no prior allergen sensitization. Also, she did not have any
symptoms when working with production of powder based on
whole shrimp. Nevertheless, our patient showed acute fall in FEV1
upon exposure, compatible with a diagnosis of asthma. TheNAGase (pmol/sec/mg dust) in the inhalable and PM4 fraction of dust from shrimp
oorganisms and NAGase
p shell granules Codﬁsh powder
able PM4 Inhalable PM4
102 5.07100 1.87100 1.53101
101–4.10102] [BD–1.20101] [BD–7.17100] [BD–1.88102]
b b ab
101 BD BD BD
100–6.36101]
101 5.07100 1.87100 1.53101
100–4.05102] [BD–1.20101] [BD–7.17100] [BD–1.88102]
ab b ab
100 BD BD BD
.55101]
BD BD BD
100 BD BD BD
.09100]
100 3.63101 1.42100 3.94100
2.04101] [BD–3.61102] [BD–2.39100] [BD–1.05101]
a c bc
100 1.93101 BD BD
.04101] [BD–6.01101]
a
1.47101 1.42100 3.94100
[BD–3.61102] [BD–2.39100] [BD–1.05101]
a a a
1.38101 BD BD
[BD–7.22100]
a
0.24 0.043 0.18
6–0.069] [0.24–0.25] [0.41–0.45] [0.17–0.19]
a c a
on a 95% signiﬁcance level. Where concentrations were below the detect limit a
lation.
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reactivity after SIC, which also could point towards asthma.
However, she also showed similar fall in FVC with a FEV1/FVC ratio
40.7 suggestive of a mild restrictive pattern. Even though she
complained of dyspnea upon exposure, she had only rarely ex-
perienced wheezing from the chest.
Although there is no general consensus for diagnosing HP
caused by occupational exposure with SIC, Munoz and colleagues
have published protocols for diagnosing HP by SIC (Munoz et al.,
2014). With 15% decrease in FVC, 1.2 °C rise in body temperature,
84% rise in neutrophils and general symptoms, our patient fulﬁlled
the suggested criteria for HP. There was no change in DLCO from
before and until 24 h after the last challenge, but DLCO was not
measured between these two time points. Further, the patient was
not investigated with high resolution CT scan, limiting our ability
to verify a diagnosis of HP.
Our patient experienced ﬂu-like symptoms and joint aches,
symptoms that have been described repeatedly in young volun-
teers introduced to farming environment (Malmberg et al., 1988;
Sigsgaard et al., 2005; Sigsgaard et al., 2008; Sigsgaard and
Schlunssen, 2004). Our investigation of the patient revealed high
levels of IgG antibodies, but no IgE, towards shrimp shell proteins.
ODTS has a nonimmunologic etiology whereas HP is typically an
immunologic disease (Seifert et al., 2003). With HP there is usually
prior sensitization to allergens in the organic dust, whereas with
ODTS there is no sensitization, and symptoms develop upon ﬁrst
exposure to the organic dust, similar to our patient. Furthermore,
neutrophilia which was seen in our patient is typical of ODTS, but
not of HP. Bronchoalveolar lavage (BAL) which has been re-
commended by others (Villar et al., 2014), was not performed. The
clinical symptoms, a rise in body temperature, and a decline in FVC
and FEV1 with a restrictive pattern could be compatible with both
HP and ODTS.
Diagnostic criteria for separating occupational asthma, ODTS
and HP are not clear-cut. It may be difﬁcult to distinguish between
asthma and HP as well as between ODTS and acute HP (Seifert
et al., 2003). Both ODTS and acute HP are characterized by non-
productive cough and dyspnea (without wheezing), fever, chills
and other ﬂu-like symptoms, usually occurring 4–8 h after ex-
posure. The symptoms usually resolve without medication within
a few days after removing the exposure. Typically, the patients
experience the same symptoms when exposed again to the same
agent, possibly with more pronounced symptoms. For HP, patients
may upon continued exposure, develop a chronic form of the
disease with lung ﬁbrosis. ODTS is described as a self-limiting
syndrome, but where some cases may progress to severe acute
lung injury (Seifert et al., 2003), and extremely high exposure
during ODTS episodes have been attributed to development of
asthma (Malmberg et al., 1993; May et al., 1990).
Microbial contaminants, such as endotoxins or bacterial con-
taminants, or high exposure to respirable particles were con-
sidered plausible causes of the condition. Due to the use of these
marine savory ingredients in food products, all marine products
are routinely tested according to international standards for the
presence of microorganisms that serves as indicators of poor hy-
giene, inadequate processing or post-process contamination of
food as well as for the presence of speciﬁc pathogens such as
Salmonella and E. coli which may cause food-borne illnesses.
However, the bacterial species, B. cereus, were identiﬁed in the
dust from the shrimp shell products and cod powder, but con-
centrations were very low and did not exceed the level of
105 CFU/g which in most cases have be associated with foodborne
emetic and diarrheal illness (Stenfors Arnesen et al., 2008). In
Gram-positive bacteria the cell wall consists of peptidoglycans and
lipoteichoic acid, which are causes of bacteria-induced in-
ﬂammation (Laitinen et al., 2001; Moreillon and Majcherczyk,2003). It has been shown that exposure to non-pathogenic bac-
teria can cause respiratory symptoms (Haverinen-Shaughnessy
et al., 2007; Rastogi et al., 2001), and that spiking of airborne dust
with Bacillus increase the inﬂammatory potential of dust samples
(Madsen et al., 2014). B. cereus is a Gram-positive bacterium that
has been found in increased concentrations in dust causing ODTS
of grass-seed workers (Madsen et al., 2015). Thus, the presence of
B. cereus and other Gram-positive bacteria may have contributed
to inﬂammation caused by the shrimp shell products. The pre-
sence of B. cereus in the marine products is not surprising as this
bacteria commonly occurs in foods and can form spores that are
extremely resistant to heat, desiccation, disinfectants and irra-
diation and thus be able to survive in the products even after
processing (Eglezos et al., 2010). A. fumigatus was also detected in
the dust of the shrimp shell products. Spores from A. fumigatus
may elicit inﬂammatory responses, and has been shown to cause
ODTS among workers in a grass seed plant (Madsen et al., 2012),
although in much higher levels than observed in the present study.
However, as A. fumigatus was only detected in the shrimp shell
products and not in the codﬁsh control powder exposure to A.
fumigatus cannot be excluded as a contributing cause of illness.
The chitinase NAGase is a widely distributed enzyme that digests
chitin and for microorganisms the presence of chitin induces
chitinase production (Chen et al., 2011). Most fungi produce the
enzyme and increased exposure to NAGase has been found in an
environment where workers developed ODTS (Madsen et al.,
2015). However, in the present study, NAGase was not found in
increased concentrations in dust from the shrimp shell products
compared to the codﬁsh product and thus we do not expect fungi
to play an important role in the development of the pulmonary
illness.
Endotoxin, which was conﬁrmed in the powder in relatively
high levels has been associated with ODTS in occupational settings
(Basinas et al., 2012; Madsen et al., 2012). Endotoxin is a lipopo-
lysaccharide from the cell-wall of gram-negative bacteria, while B.
cereus is a gram-positive bacterium and could therefore not be the
source of the endotoxin in the shrimp shell powder. Although
endotoxin can probably be released in minute amounts from
gram-negative bacteria while they are still growing, endotoxin will
for the most part remain associated with the cell wall until dis-
integration of the organisms. Thus, the endotoxin concentrations
that were measured in the shrimp shell powder are likely to be
remains of gram-negative bacteria associated with the shrimp
before it was boiled and grounded to powder, which would kill the
bacteria and causing release of endotoxins, and thereby explaining
why the concentration of the endotoxin was high, but not the
concentration of bacteria in general. Another potential source
which has been suggested to be associated with airway in-
ﬂammation and respiratory symptoms, are β(1-3)glucans which
can be found in fungi, yeast, some bacteria and plant material
(Douwes, 2005). We have earlier in a study of ﬁsh ﬁlleting workers
showed how the rinsing water was the component of the work
environment with the highest inﬂammatory potential (IL-8 re-
lease) in an ex vivo assay, and signiﬁcantly higher in ﬁlleting
workers than in controls there was a release caused by endotoxin
and a low effect associated to glucan (Bonlokke et al., 2004), so we
expect the effect to be caused by endotoxin in combination with
other components in the powder. β(1-3)glucans was not measured
in the present study, but given the dryness of the shrimp shell
powder and the strict control with bacterial contamination of the
products, the biomass of fungi and bacteria, it seems unlikely that
β(1-3)glucans are an important contributor to the respiratory
problems observed in the present study.
Endotoxin was also detected in the codﬁsh powder; although in
lower concentrations compared to the shrimp shell powder and
granules. The patient experienced no respiratory or ﬂu-like
R.J. Bertelsen et al. / Environmental Research 148 (2016) 491–499498symptoms while working with codﬁsh powder or with any of the
other marine ingredients produced in the company. The cell assays
showed higher TIP in response to exposure to shrimp shell powder
and granules compared to codﬁsh powder and also compared to
pure endotoxin exposure. Thus, it is possible that endotoxin in
combination with the other microbial components (fungi and
bacteria) is responsible for the cell responses and the respiratory
and clinical symptoms experienced by the patient, or that the high
fraction of respirable dust particles and the microbial components
and shrimp shell proteins together are responsible for the ob-
served effect.
Taking into consideration that workers are exposed for several
hours for several consecutive work shifts during the production of
shrimp shell powder, the exposure levels will be much higher than
the exposure during the challenges in SIC. This is in line with the
milder symptoms experienced with SIC as compared to the
symptoms during exposure at work. The patient reported that she
had on more than one occasion measured temperatures 439 °C in
the evenings after several consecutive days working with shrimp
shell powder. This is in contrast to the clinical picture among
cotton mill workers, where byssinosis (previously called “Monday
Fever”) which is caused by endotoxin exposure was ﬁrst described,
and the symptoms in the early stage of the disease were most
acute on Mondays (Er et al., 2016). Continued exposure to respir-
able dust fraction with high concentrations of endotoxin, could in
worst case scenario progress to severe acute lung injury (Seifert
et al., 2003). Furthermore, long term occupational exposure to
high levels of endotoxin have previously been shown to cause
reduced lung function even one year after cessation, although
those workers had been exposed to much higher levels than we
would expect the patient in the present study to experience
(Skogstad et al., 2012). Nevertheless, the patient should avoid
exposure in order to prevent chronic disease.
In conclusion, exposure to shrimp shell powder during SIC
caused a 15% decrease in FVC, a 23% decrease in FEV1, moderate
temperature rise, increase in neutrophils and respiratory and
general symptoms similar to those experienced during regular
working conditions. IgE mediated mechanisms were not indicated,
but high levels of precipitating IgG antibodies were measured in
serum from the patient. The ROS production indicated higher in-
ﬂammatory potential with shrimp shell powder, than with en-
dotoxin alone. The combination of endotoxin and other bacterial
components in the shrimp shell powder, the high fraction of re-
spirable dust, ﬂu-like symptoms, and increase in monocytes,
suggest a diagnosis of ODTS. However, based on the results from
SIC, HP cannot be excluded as a differential diagnosis. Due to the
lack of allergic sensitization and sensitization phase, we did not
consider allergic asthma as relevant, However, the observed de-
cline in FEV1 suggest that work related (non-allergic) asthma must
be considered and attempted treated. There is a need for better
clariﬁcation of the diagnostic criteria to help differentiate between
asthma, organic dust toxic syndrome and hypersensitivity
pneumonitis.Contributorship statement
RJB, ØS, BEH, JK, TBA, and CS initiated and designed the study,
AMM, TS, KU, and TvD contributed with laboratory analysis, RJB
drafted the manuscript, and all other authors contributed with
interpretation of data for the work and revising the manuscript
critically for important intellectual content. All authors approved
the ﬁnal version of the manuscript.Competing interests
Non declared.Funding
There are no funders to report for this submission.Ethics
This study was approved by the Regional Committee for Med-
ical and Health Research Ethics (2015/61). The company and the
patient consented to publication of the results.Appendix A. Supporting information
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.envres.2016.04.033.References
481, E., 1993. Workplace Atmospheres. Size Fraction Deﬁnitions for Measurement of
Airborne Particles.
Abdel Rahman, A.M., et al., 2012. Simultaneous determination of two major snow
crab aeroallergens in processing plants by use of isotopic dilution tandem mass
spectrometry. Anal. Bioanal. Chem. 403, 821–831.
Basinas, I., et al., 2012. Sensitisation to common allergens and respiratory symp-
toms in endotoxin exposed workers: a pooled analysis. Occup. Environ. Med.
69, 99–106.
Basinas, I., et al., 2013. Exposure to inhalable dust and endotoxin among Danish pig
farmers affected by work tasks and stable characteristics. Ann. Occup. Hyg. 57,
1005–1019.
Basinas, I., et al., 2015. A comprehensive review of levels and determinants of
personal exposure to dust and endotoxin in livestock farming. J. Expo. Sci.
Environ. Epidemiol. 25, 123–137.
Baur, X., Bakehe, P., 2014. Allergens causing occupational asthma: an evidence-
based evaluation of the literature. Int. Arch. Occup. Environ. Health 87,
339–363.
Bonlokke, J.H., et al., 2004. Respiratory symptoms and ex vivo cytokine release are
associated in workers processing herring. Int. Arch. Occup. Environ. Health 77,
136–141.
Bonlokke, J.H., et al., 2012. Snow crab allergy and asthma among Greenlandic
workers–a pilot study. Int. J. Circumpolar Health 71, 19126.
Brinchmann, B.C., et al., 2011. A possible role of chitin in the pathogenesis of asthma
and allergy. Ann. Agric. Environ. Med. 18, 7–12.
Cartier, A., et al., 2004. Prevalence of crab asthma in crab plant workers in New-
foundland and Labrador. Int. J. Circumpolar Health 63 (Suppl. 2), S333–S336.
Chen, J.K., et al., 2011. N-acetyl glucosamine obtained from chitin by chitin de-
grading factors in Chitinbacter tainanesis. Int. J. Mol. Sci. 12, 1187–1195.
Crapo, R.O., et al., 2000. Guidelines for methacholine and exercise challenge test-
ing-1999. This ofﬁcial statement of the American Thoracic Society was adopted
by the ATS Board of Directors, July 1999. Am. J. Respir. Crit. Care Med. 161,
309–329.
Douwes, J., 2005. (1–43)-Beta-D-glucans and respiratory health: a review of the
scientiﬁc evidence. Indoor Air 15, 160–169.
Eglezos, S., et al., 2010. The prevalence and concentration of Bacillus cereus in retail
food products in Brisbane, Australia. Foodborne Pathog. Dis. 7, 867–870.
Er, M., et al., 2016. Byssinosis and COPD rates among factory workers manu-
facturing hemp and jute. Int. J. Occup. Med Environ. Health 29, 55–68.
Gautrin, D., et al., 2010. Occupational asthma and allergy in snow crab processing in
Newfoundland and Labrador. Occup. Environ. Med. 67, 17–23.
Granslo, J.T., et al., 2009. Occupational allergy to Artemia ﬁsh fry feed in aqua-
culture. Occup. Med 59, 243–248.
Haverinen-Shaughnessy, U., et al., 2007. Personal and microenvironmental con-
centrations of particles and microbial aerosol in relation to health symptoms
among teachers. J. Expo. Sci. Environ. Epidemiol. 17, 182–190.
Helaskoski, E., et al., 2014. Occupational asthma, rhinitis, and contact urticaria
caused by oxidative hair dyes in hairdressers. Ann. Allergy Asthma Immunol.
112, 46–52.
Hinson, A.V., et al., 2014. The prevalence of byssinosis among cotton workers in the
north of Benin. Int. J. Occup. Environ. Med. 5, 194–200.
Kogevinas, M., et al., 2007. Exposure to substances in the workplace and new-onset
asthma: an international prospective population-based study (ECRHS-II). Lan-
cet 370, 336–341.
R.J. Bertelsen et al. / Environmental Research 148 (2016) 491–499 499Laitinen, S., et al., 2001. Evaluation of exposure to airborne bacterial endotoxins and
peptidoglycans in selected work environments. Ann. Agric. Environ. Med. 8,
213–219.
Madsen, A.M., et al., 2012. Organic dust toxic syndrome at a grass seed plant caused
by exposure to high concentrations of bioaerosols. Ann. Occup. Hyg. 56,
776–788.
Madsen, A.M., et al., 2014. Exposure and preventive measure to reduce high and
daily exposure to Bacillus thuringiensis in potted plant production. Ann. Occup.
Hyg. 58, 664–676.
Madsen, A.M., et al., 2015. Microbial diversity in bioaerosol samples causing ODTS
compared to reference bioaerosol samples as measured using Illumina se-
quencing and MALDI-TOF. Environ. Res. 140, 255–267.
Malmberg, P., et al., 1988. Incidence of organic dust toxic syndrome and allergic
alveolitis in Swedish farmers. Int. Arch. Allergy Appl. Immunol. 87, 47–54.
Malmberg, P., et al., 1993. Exposure to microorganisms associated with allergic
alveolitis and febrile reactions to mold dust in farmers. Chest 103, 1202–1209.
Malo, J.L., et al., 1997. Detection of snow-crab antigens by air sampling of a snow-
crab production plant. Clin. Exp. Allergy 27, 75–78.
Mapp, C.E., et al., 2005. Occupational asthma. Am. J. Respir. Crit. Care Med. 172,
280–305.
May, J.J., et al., 1990. Organic dust toxic syndrome: a follow-up study. Am. J. Ind.
Med. 17, 111–113.
Michel, O., et al., 1997. Dose-response relationship to inhaled endotoxin in normal
subjects. Am. J. Respir. Crit. Care Med. 156, 1157–1164.
Michel, O., 2000. Systemic and local airways inﬂammatory response to endotoxin.
Toxicology 152, 25–30.
Moreillon, P., Majcherczyk, P.A., 2003. Proinﬂammatory activity of cell-wall con-
stituents from gram-positive bacteria. Scand. J. Infect. Dis. 35, 632–641.
Morell, F., et al., 2011. Chacinero's lung - hypersensitivity pneumonitis due to dry
sausage dust. Scand. J. Work Environ. Health 37, 349–356.
Munoz, X., et al., 2014. Diagnostic yield of speciﬁc inhalation challenge in hy-
persensitivity pneumonitis. Eur. Respir. J. 44, 1658–1665.
Rastogi, D., et al., 2001. Host-bacterial interactions in the initiation of inﬂammation.
Paediatr. Respir. Rev. 2, 245–252.
Raulf, M., et al., 2014. Monitoring of occupational and environmental aeroallergens
– EAACI Position Paper. Concerted action of the EAACI IG Occupational Allergy
and Aerobiology & Air Pollution. Allergy 69, 1280–1299.
Rylander, R., et al., 1989. Pulmonary function and symptoms after inhalation of
endotoxin. Am. Rev. Respir. Dis. 140, 981–986.Seifert, S.A., et al., 2003. Organic dust toxic syndrome: a review. J. Toxicol. Clin.
Toxicol. 41, 185–193.
Sigsgaard, T., et al., 2005. Microbial cell wall agents as an occupational hazard.
Toxicol. Appl. Pharmacol. 207, 310–319.
Sigsgaard, T., et al., 2008. The role of innate immunity in occupational allergy: re-
cent ﬁndings. Curr. Opin. Allergy Clin. Immunol. 8, 120–125.
Sigsgaard, T., et al., 2015. The change in nasal inﬂammatory markers after intranasal
challenges with particulate chitin and lipopolysaccharide: a randomized,
double-blind, placebo-controlled, crossover study with a positive control. Int.
Forum Allergy Rhinol. 5, 716–723.
Sigsgaard, T., Schlunssen, V., 2004. Occupational asthma diagnosis in workers ex-
posed to organic dust. Ann. Agric. Environ. Med. 11, 1–7.
Sikkeland, L.I., et al., 2008. Circulating lipopolysaccharides in the blood from “bio-
protein” production workers. Occup. Environ. Med. 65, 211–214.
Skogstad, M., et al., 2012. Long-term occupational outcomes of endotoxin exposure
and the effect of exposure cessation. Occup. Environ. Med. 69, 107–112.
Smit, L.A., et al., 2006. Agricultural seed dust as a potential cause of organic dust
toxic syndrome. Occup. Environ. Med. 63, 59–67.
Spaan, S., et al., 2006. Exposure to inhalable dust and endotoxins in agricultural
industries. J. Environ. Monit. 8, 63–72.
Stenfors Arnesen, L.P., et al., 2008. From soil to gut: Bacillus cereus and its food
poisoning toxins. FEMS Microbiol. Rev. 32, 579–606.
Thorne, P.S., 2000. Inhalation toxicology models of endotoxin- and bioaerosol-in-
duced inﬂammation. Toxicology 152, 13–23.
Thorne, P.S., et al., 2004. Working group report 4: exposure assessment for biolo-
gical agents. Am. J. Ind. Med. 46, 419–422.
Thorne, P.S., et al., 2005. Endotoxin exposure is a risk factor for asthma: the national
survey of endotoxin in United States housing. Am. J. Respir. Crit. Care Med. 172,
1371–1377.
Timm, M., et al., 2006. Utilization of the human cell line HL-60 for chemilumi-
nescence based detection of microorganisms and related substances. Eur. J.
Pharm. Sci. 27, 252–258.
Timm, M., et al., 2009. Assessment of the total inﬂammatory potential of bioaer-
osols by using a granulocyte assay. Appl. Environ. Microbiol. 75, 7655–7662.
Vandenplas, O., et al., 2014. Speciﬁc inhalation challenge in the diagnosis of occu-
pational asthma: consensus statement. Eur. Respir. J.
Villar, A., et al., 2014. Bronchial inﬂammation in hypersensitivity pneumonitis after
antigen-speciﬁc inhalation challenge. Respirology 19, 891–899.
